<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00720343</url>
  </required_header>
  <id_info>
    <org_study_id>AAAC8413</org_study_id>
    <secondary_id>1R21AT004708-01A1</secondary_id>
    <nct_id>NCT00720343</nct_id>
  </id_info>
  <brief_title>Effect of Oral Choline Supplementation on Postoperative Pain</brief_title>
  <official_title>Effect of Oral Choline Supplementation on Postoperative Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research will test whether consuming additional choline before gynecological surgery
      decreases postoperative pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      More than 70% of the patients undergoing surgery in the USA, experience moderate to severe
      pain after the surgery in spite of being treated for pain. We will test whether choline will
      produce an effective additional analgesic action for postoperative pain treatment. Choline
      and lecithin are safe and are available for consumers as over-the-counter nutritional
      supplements. Choline supplementation decreases postoperative pain in rodents. Also Nicotine
      decreases postoperative pain in humans and since choline acts on the same receptors as
      nicotine, choline supplementation may be effective as an analgesic without the risks of
      addiction and the side effects like high heart rate and blood pressure.

      Sixty women between the ages 18 and 60 undergoing open abdominal gynecological surgeries will
      be studied. We will not study people with chronic pain, drug abuse, and/or nicotine use over
      the past six months, current pregnancy or breastfeeding, allergy to soy, or inability to take
      any drug that we will use in the study.

      Patients will take 10 tablets (choline or gelatin powder placebo) the night before surgery.
      After anesthesia, a second dose will be given into a tube that goes into the patient's
      stomach. One tablespoon of blood (15 mL) will be drawn five times to measure genetics,
      changes in levels of plasma choline and inflammatory markers: blood will be drawn at the
      preoperative visit, three times on the day of surgery and once 24 hours postoperatively. At
      24 hours after surgery and on their follow-up visit with their doctor, the patient's surgical
      wound will be photographed and patients will complete a survey on satisfaction with
      treatment.

      Primarily we are looking at the pain scores after surgery and secondarily at the pain
      medication use, plasma choline levels, wound healing and satisfaction with pain treatment.

      This is a randomized double blind study. Patients will consume ten tablets (10g choline or
      placebo) the night before undergoing gynecological surgery and 10 tablets the morning of
      surgery. We will measure pain after surgery, baseline and postoperative plasma choline, and
      test genetics.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI left the institution.
  </why_stopped>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of Pain</measure>
    <time_frame>24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of Nausea</measure>
    <time_frame>24 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of High Blood Choline Concentration</measure>
    <time_frame>24 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of Opioid Use</measure>
    <time_frame>24 hours after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Choline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral choline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Gelatin Capsule</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Choline</intervention_name>
    <description>Oral Choline 20 grams before surgery</description>
    <arm_group_label>Choline</arm_group_label>
    <other_name>Tricholine 1200</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Gelatin Capsule</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Gelatin Capsule</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  open pelvic surgery

          -  able to swallow pills

        Exclusion Criteria:

          -  chronic pain

          -  opioid use

          -  pregnancy

          -  lactation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela Flood, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2008</study_first_submitted>
  <study_first_submitted_qc>July 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2008</study_first_posted>
  <results_first_submitted>March 23, 2016</results_first_submitted>
  <results_first_submitted_qc>March 23, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 25, 2016</results_first_posted>
  <last_update_submitted>March 23, 2016</last_update_submitted>
  <last_update_submitted_qc>March 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Choline</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The principal investigator has left the institution. Attempts to contact the PI have been unsuccessful. Columbia will never have access to the data. Thus, data will not be analyzed. The only information available is the number of participants who started and completed the study, which was last reported to and approved by the IRB in March 2011.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Choline or Placebo</title>
          <description>Oral choline or Placebo
Choline: Oral Choline or Placebo 20 grams before surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48">3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No data</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Data per arm is not available. Columbia will never have access to this data.</population>
      <group_list>
        <group group_id="B1">
          <title>Choline or Placebo</title>
          <description>Oral choline or Placebo
Choline: Oral Choline or Placebo 20 grams before surgery</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="54"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>18 to 60 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Prevalence of Pain</title>
        <time_frame>24 hours after surgery</time_frame>
        <population>The principal investigator has left the institution. Attempts to contact the PI have been unsuccessful. Columbia will never have access to the data. Thus, data will not be analyzed. The only information available is the number of participants who started and completed the study, which was last reported to and approved by the IRB in March 2011.</population>
        <group_list>
          <group group_id="O1">
            <title>Choline</title>
            <description>Oral choline
Choline: Oral Choline 20 grams before surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Gelatin Capsule
Placebo: Gelatin Capsule</description>
          </group>
        </group_list>
        <measure>
          <title>Prevalence of Pain</title>
          <population>The principal investigator has left the institution. Attempts to contact the PI have been unsuccessful. Columbia will never have access to the data. Thus, data will not be analyzed. The only information available is the number of participants who started and completed the study, which was last reported to and approved by the IRB in March 2011.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prevalence of Nausea</title>
        <time_frame>24 hours after surgery</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prevalence of High Blood Choline Concentration</title>
        <time_frame>24 hours after surgery</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prevalence of Opioid Use</title>
        <time_frame>24 hours after surgery</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>The principal investigator has left the institution. Attempts to contact the PI have been unsuccessful. Columbia will never have access to the data. Thus, data will not be analyzed. The only information available is the number of participants who started and completed the study, which was last reported to the IRB in February 2011.</desc>
      <group_list>
        <group group_id="E1">
          <title>Choline</title>
          <description>Oral choline
Choline: Oral Choline 20 grams before surgery</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Gelatin Capsule
Placebo: Gelatin Capsule</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>CU PRS Administrator</name_or_title>
      <organization>Columbia University</organization>
      <phone>212-342-1643</phone>
      <email>crchelp@columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

